Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Non-Current Assets (2019 - 2025)

Historic Non-Current Assets for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $310.4 million.

  • CureVac's Non-Current Assets rose 488.41% to $310.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $310.4 million, marking a year-over-year increase of 488.41%. This contributed to the annual value of $295.4 million for FY2024, which is 1140.58% down from last year.
  • Per CureVac's latest filing, its Non-Current Assets stood at $310.4 million for Q3 2025, which was up 488.41% from $304.6 million recorded in Q2 2025.
  • In the past 5 years, CureVac's Non-Current Assets ranged from a high of $339.5 million in Q1 2024 and a low of $231.3 million during Q2 2021
  • In the last 5 years, CureVac's Non-Current Assets had a median value of $295.7 million in 2024 and averaged $294.0 million.
  • As far as peak fluctuations go, CureVac's Non-Current Assets soared by 19823195.89% in 2021, and later crashed by 1537.38% in 2025.
  • Quarter analysis of 5 years shows CureVac's Non-Current Assets stood at $249.6 million in 2021, then increased by 12.98% to $282.0 million in 2022, then rose by 18.21% to $333.4 million in 2023, then dropped by 11.41% to $295.4 million in 2024, then grew by 5.09% to $310.4 million in 2025.
  • Its Non-Current Assets was $310.4 million in Q3 2025, compared to $304.6 million in Q2 2025 and $287.3 million in Q1 2025.